Alternative Dosing Scheme of Pomalidomide 4 mg Every Other Day Versus Pomalidomide 2 mg and 4 mg Every Day; the POMAlternative Study

Clinical trial NCT05555329 · COMPLETED

Trial details

NCT number: NCT05555329
Sponsor: Amsterdam UMC, location VUmc
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Multiple Myeloma Multiple Myeloma, Refractory

Start date: 2022-12-01
Primary completion: 2024-02-14
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.